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2009.-Mitochondrial dysfunction is involved in pathopysiology of ischemia-reperfusion-induced acute kidney injury (AKI). The p66shc adaptor protein is a newly recognized mediator of mitochondrial dysfunction, which might play a role in AKI-induced renal tubular injury. Oxidative stress-mediated Serine36 phosphorylation of p66shc facilitates its transportation to the mitochondria where it oxidizes cytochrome c and generates excessive amount of reactive oxygen species (ROS). The consequence is mitochondrial depolarization and injury. Earlier we determined that p66shc plays an essential role in injury of cultured mouse renal proximal tubule cells during oxidative stress. Here, we studied the role of p66shc in ROS generation and consequent mitochondrial dysfunction during oxidative injury in renal proximal tubule cells. We employed p66shc knockdown renal proximal tubule cells and cells that overexpress wild-type, Serine phosphorylation (S36A), or cytochrome c-binding (W134F) mutants of p66shc. Inhibition of the mitochondrial electron transport chain or the mitochondrial permeability transition revealed that hydrogen peroxide-induced injury is mitochondrial ROS and consequent mitochondrial depolarization dependent. We also found that through Ser36 phosphorylation and mitochondria/cytochrome c binding, p66shc mediates those effects. We propose a similar mechanism in vivo as we demonstrated mitochondrial binding of p66shc as well as its association with cytochrome c in the postischemic kidneys of mice. Thus, manipulating p66shc might offer a new therapeutic modality to ameliorate renal ischemic injury.
reactive oxygen species MITOCHONDRIAL DYSFUNCTION is involved in either the etiology or underlying pathology of a variety of renal diseases including ischemia-reperfusion (I/R)-induced acute kidney injury (AKI) (9, 26, 31) . I/R injury produces excessive amounts of reactive oxygen species (ROS) including hydrogen peroxide (H 2 O 2 ), which is responsible for the injury (1, 16, 49) . Conversely, scavengers/antioxidants blunt oxidative stress and consequent injury both in vivo and in vitro (11, 14, 34) . The major source of ROS is the mitochondrial electron transport chain (ETC) (17, 26, 30) . It has been demonstrated that excessive ROS production induces mitochondrial permeability transition (MPT) (17) that rapidly depolarizes the mitochondrial membrane and contributes to apoptotic or necrotic death in renal cells (15, 26, 46) .
The adaptor protein p66shc is a newly recognized mediator of mitochondrial dysfunction (21, 41) . It has been demonstrated that p66shc is activated by oxidative stress by phosphorylation at its Ser36 residue, which facilitates its translocation to the mitochondrial intermembrane space where it binds and oxidizes cytochrome c (21, 41) . The consequence is an excessive generation of ROS, which, in turn, depolarizes the mitochondria (21, 41) .
Earlier, we reported that p66shc is Ser36 phosphorylated during oxidative injury in renal proximal tubular cells in vitro and in the postischemic kidney in vivo (2) . We proved that the Ser36-phosphorylated p66shc contributes to cell death through inhibiting the prosurvival EGFR-ras-ERK pathway (2) . However, the role of p66shc in ROS generation and mitochondrial dysfunction in renal proximal tubules remains to be elucidated.
The aim of the present study was to determine whether p66shc contributes to ROS production and consequent mitochondrial dysfunction in renal proximal tubules during oxidative injury.
METHODS
Antibodies, reagents. Antibodies were obtained from the following sources: anti-shc (BD Transduction Laboratories, Lexington, KY), anti-phospho-Ser36p66shc and anti-p66shc (Alexis Biochemicals/ Axxora, San Diego, CA), and anti-cytochrome c (Cell Signaling Technology, Beverly, MA). Control IgG antibodies were obtained from Santa Cruz Biotechnology (La Jolla, CA). N-acetyl-cysteine, the NAPDH oxidase inhibitor diphenyleneiodium chloride (DPI), the xanthine oxidase inhibitor allopurinol (Allo), the mitochondrial inhibitor rotenone (Rot), and antimycin A (AntA) were purchased from Sigma (St. Louis, MO). Tempol and Ebselen were purchased from Enzo Life Sciences (Plymouth Meeting, PA).
Cell lines, animals. The immortalized mouse proximal tubule epithelial cell line (TKPTS) is a gift from Dr. Bello-Reuss (18) and was maintained as described earlier (2) . Oxidative injury was induced by treatment of semiconfluent cells with 200 M H 2O2. In other set of experiments, a p66shc knockdown (k.d.) derivative of TKPTS cells and its vector-transfected counterpart were used as described earlier (2) .
For in vivo experiments, 8-to 10-wk-old male C57BL/6 mice (Harlan Laboratories) were used and housed at the Laboratory Animal Facility at the University of Mississippi Medical Center (Jackson, MS). Before induction of renal ischemia, the animals were anesthetized by ketamine (50 mg/kg ip) and xylazine (10 mg/kg ip). Kidneys were exposed through flank incision and subjected to bilateral ischemia by clamping both renal pedicles with nontraumatic vascular microclamps (Fine Science Tools). After 40 min, the clamps were removed and reperfusion of the kidneys was visually confirmed and the incisions were closed. During the surgery and the postsurgical recovery phase, rectal temperature was monitored and maintained at 36 -37°C using heating pads and overhead lamps. After the surgery, the animals were monitored for recovery and then returned to their cages and allowed free access to food and water. Twenty-four hours after the ischemia, animals were painlessly killed in accordance with methods of euthanasia approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Mississippi Medical Center: blood was drawn and kidneys were removed for further molecular studies. Serum creatinine levels were 0.35 Ϯ 0.1 mg/dl in control animals that was increased to 1.78 Ϯ 0.18 24 h after reperfusion. Blood urea nitrogen levels were 20 Ϯ 5 mg/dl in control and 89 Ϯ 35 mg/dl in ischemic animals.
Assessment of cell injury. Cell injury was assessed by the fluorescent "CytoTox-One Homogenous Membrane Integrity" assay kit (Promega, Madison, WI). Accordingly, 24 h after treatment an aliquot of the growth medium was removed and saved. The monolayer was lysed according to the manufacturer's recommendation and LDH content was determined both in the medium and cell lysate. LDH release was calculated as percentage of LDH content in the medium compared with the total LDH content (medium ϩ lysate).
Protein isolation, Western blotting, and immunoprecipitation. Kidneys were removed and homogenized in a RIPA buffer as described earlier (3, 4) . Similarly, monolayers of cells were lysed in a RIPA buffer. Protein content was determined by using a BioRad Protein Determination assay (Bio-Rad, Hercules, CA). One-hundred micrograms of protein from cell or tissue lysates were separated by SDS-PAGE electrophoresis and transferred to a PVDF membrane (Bio-Rad). The filters were hybridized with the appropriate primary antibodies followed by a horseradish peroxidase-conjugated secondary antibody. The bands were visualized by an ECL method (Amersham) and quantified by densitometry (UnScan-It, Silk Scientific, Ore, UT). For immunoprecipitation, 500 g total cell lysates were incubated with the appropriate primary antibody overnight at 4°C using the Catch and Release v2.0 reversible immunoprecipitation system (Millipore, Charlottesville, VA). Immunoprecipitated proteins were resolved by SDS-PAGE as described above. In immunoprecipitation studies, negative control IgGs were also used to determine crossreactivity.
Plasmid construction and transient transfection. Construction of the following plasmids was described elsewhere (19) : wild-type p66shc, the S36A mutant of p66shc in which the Serine36 residue was mutated to alanine. The HA-tagged cytochrome c-binding mutant (W134F) of p66shc was derived from the HA-p66shc plasmid by site-directed mutagenesis (Agilent, Wilmington, DE) using 5=-GGG GGC GAG GAG TTC ACC AGA CAC GGG AG-3= and 5=-CTC CCG TGT CTG GTG AAC TCC TCG CCC CC-3= primers. Plasmids were transiently transfected into cells by the Lipofectamine LTX reagent (Invitrogen, Grand Island, NY) in six-well plates.
Isolation of mitochondria. To isolate mitochondria from cultured TKPTS cells, we used the "Mitochondria isolation kit for cultured cells" kit (Pierce, Rockford, IL). Briefly, cells were trypsinized, collected by centrifugation, and lysed as recommended. The mitochondrial fraction was obtained by differential centrifugation and lysed in a CHAPS-TBS buffer. To isolate mitochondria from mouse kidney, a mitochondria isolation kit for tissue (Pierce) was used. Briefly, mouse kidneys were homogenized in a dounce homogenizer and lysed as recommended. The mitochondrial fraction was obtained by differential centrifugation and lysed in a CHAPS-TBS buffer.
Measurement of ROS production. Intracellular generation of ROS was determined following a microplate assay procedure described by Wang and Joseph (48) using the oxidant-sensitive 2=,7=-dichlorofluorescein-diacetate (DCFDA; Invitrogen). Cells grown in T25 flask were treated if needed and isolated with trypsinization and then loaded with 100 M DCFDA in HBSS for 30 min at 37°C. After incubation, the dye was washed away with fresh HBSS and cells were placed in wells of a 96-well plate (0.5 ϫ 10 6 cell/well). H2O2 was added to the wells and increase in fluorescence at 485 nmexc/530 nmem was recorded in 30-min intervals for up to 120 min in a fluorescence plate reader (Fluorocount, Packard). ROS production was calculated as changes in fluorescence·30 min Ϫ1 ·0.5 ϫ 10 6 cells Ϫ1 and expressed as percentage of the corresponding untreated values. The linear phase of the curve (between 60 and 90 min after adding of H 2O2) was used for calculation.
Mitochondrial localization of ROS production. Cells grown on collagen-coated chambered coverglass were treated with 200 M H 2O2 for 30 min and then loaded with the mitochondrial ROS-sensing dye dihydrorhodamine 123 (10 M DHR 123, Invitrogen) and 250 M MitoTracker Red CMXRos (Invitrogen) in DPBS at 37°C. After being washed with DBPS, green (DHR 123) or red (MitoTracker Red) fluorescence was detected at room temperature by a Nikon Eclipse TS100F inverted fluorescence microscope equipped with CY3/FITC filters and a camera (DS Cooled Camera head DS-Ql1). Images were captured using NIS Elements for Basic Research 3.0 (Nikon) software (magnification ϫ400).
Mitochondrial depolarization. Mitochondrial depolarization was determined by the polarity sensor fluorescent dye JC-1 (Invitrogen). J aggregates (red fluorescence) are formed in the polarized mitochondria: conversely, mitochondrial depolarization is indicated by a decrease in red fluorescence. Accordingly, cells grown in T25 flasks were isolated by trypsinization and loaded with 200 nM JC-1 in HBSS for 30 min at 37°C. Cells were then washed with HBSS and placed in wells of a 96-well plate (0.5 ϫ 10 6 cells/well) and H2O2 or other reagents were added as indicated in the figure legends. The extent of mitochondrial depolarization was assessed by measuring the decrease of red (J aggregate) fluorescence at 530 nm exc/590 nmem as recommended by the manufacturer and also described by others (41) . Changes in JC-1 fluorescence were calculated as decrease of red fluorescence/0.5 ϫ 10 6 cells between 10 and 20 min after adding H2O2 and expressed as percentage of the corresponding untreated values.
Depolarization of the mitochondria was also confirmed by fluorescence microscopy. Briefly, cells were grown on collagen-coated chambered coverglass and treated as described in the appropriate figure legends. After treatment, cells were washed with fresh medium and loaded with 200 nM JC-1 in fresh medium for 15 min. After being washed with DPBS, red (polarized mitochondria) and green (depolarized mitochondria) fluorescence was detected at room temperature by a Nikon Eclipse TS100F inverted fluorescence microscope equipped with CY3/FITC filters and a camera (DS Cooled Camera head DS-Ql1). Images were captured using NIS Elements for Basic Research 3.0 (Nikon) software (magnification ϫ400).
Statistical analysis. Continuous variables were expressed as means and SD. Statistical differences between the treated and control groups were determined by Student's t-test. Differences between means were considered significant if P Ͻ 0.05. All analyses were performed using the SigmaStat 3.5 (Systat, San Jose, CA) software package.
RESULTS

H 2 O 2 generates ROS via the mitochondrion that requires Serine36 phosphorylation and cytochrome c binding of p66shc.
In our in vitro studies, we used the H 2 O 2 model to induce oxidative stress in TKPTS cells as described earlier (2, 3) . First, we determined whether H 2 O 2 -generated ROS is responsible for injury of TKPTS cells. Accordingly, TKPTS cells were treated with 200 M H 2 O 2 and ROS generation was determined between 60 and 90 min after treatment as described in METHODS. LDH release was determined 24 h after treatment. Figure 1A shows that H 2 O 2 treatment significantly increased both ROS production and LDH release. Pretreatment of cells with the antioxidant N-acetyl-cysteine, the superoxide dismutase mimetic tempol, or the glutathione peroxidase mimetic Ebselen before treatment with 200 M H 2 O 2 significantly attenuated both ROS production and LDH release (Fig. 1A) , suggesting that the H 2 O 2 -induced ROS is responsible for injury. Next, we sought the answer to what is the origin of this H 2 O 2 -generated ROS. Accordingly, TKPTS cells were pretreated with the xanthine oxidase inhibitor Allo, the NADPH oxidase inhibitor diphenyleneiodium, and the mitochondrial ETC inhibitors Rot or AntA before treatment with 200 M H 2 O 2 . Apparently, only Rot or AntA decreased H 2 O 2 -induced ROS production significantly (Fig. 1) , which suggests that the source of ROS is the mitochondria. This notion was further confirmed by fluorescence microscopy: cells were treated with H 2 O 2 for 30 min and then were loaded with the mitochondrial ROS-sensing dye DHR123 as well as MitoTracker Red. Colocalization of the green (DHR123-ROS) and red (mitochondria) fluorescence (Fig. 2, A-C ) also established the mitochondrion as source of the H 2 O 2 -induced ROS.
The next question was whether p66shc is involved in this ROS production? To answer the question, a p66shc k.d. cell line was used that was generated from TKPTS cells as described elsewhere (2) . The extent of k.d. is ϳ80% in the k.d. line as published earlier (2). We found that both endogenous and H 2 O 2 -induced ROS production was significantly lower in the p66shc k.d. cell line compared with the vector-transfected counterpart (Fig. 3A) . In addition, ectopic overexpression of WT-p66shc increased (Fig. 3B) while overexpression of Ser36 phosphorylation-deficient (S36A) or cytochrome c-binding impaired (W134F) mutant decreased H 2 O 2 -induced ROS production (Fig. 3B) . These results indicate that the Ser36-phosphorylated p66shc and its binding to cytochrome c are important in mitochondrial ROS production.
p66shc binds to the mitochondria and cytochrome c during oxidative injury in vitro and in vivo. Others demonstrated that the Ser36-phosphorylated p66shc binds to the mitochondria and within it the cytochrome c to stimulate ROS release (21) (Fig. 4A) . Next, TKPTS cells were transiently transfected with the HA-tagged wt or S36A mutant of p66shc. Interestingly, both WT-p66shc and its S36A mutant bound to the mitochondria in untreated cells (Fig. 4A) . However, mitochondrial binding of the wt but not the S36A mutant of p66shc was increased after treatment with H 2 O 2 . Since the p66shc antibody does not differentiate between wt p66shc and S36A mutant, blots were reprobed with an anti-HA antibody that confirmed that the increased binding of p66shc in transfected cells was due to the exogenous p66shc. Probing with an anti-phosphoSerine36p66shc antibody revealed that H 2 O 2 treatment increased Ser36 phosphorylation of endogenous and exogenous (wt) p66shc together with its mitochondrial binding. In contrast, the Ser36 phosphorylationdeficient mutant is not phosphorylated after treatment with H 2 O 2 and consequently, its mitochondrial binding is unchanged. Reprobing with an anti-cytochrome c antibody revealed equal amounts of immunoprecipitated cytochrome c. These results imply that Ser36 phosphorylation is necessary for the oxidative stress-induced but not the basal mitochondrial binding.
In the mitochondria, p66shc binds to cytochrome c and oxidizes it to generate ROS (H 2 O 2 ) (21). To check this hypothesis, TKPTS cells were treated with 200 M H 2 O 2 for 30 min or left untreated and equal amounts of cell lysates were immunoprecipitated with an anti-cytochrome c antibody. The immunoprecipitates were blotted with anti-p66shc antibody followed by an anti-cytochrome c antibody. Results in Fig. 4B show that cytochrome c coprecipitated with p66shc in H 2 O 2 -treated native cells. Anti-IgG antibody was used to determine specificity of the immunoprecipitation. Surprisingly, either the transiently transfected wt or S36A mutant of p66shc bound to cytochrome c. However, H 2 O 2 treatment increased only the wt but not the S36A association with cytochrome c similar to mitochondrial binding (Fig. 4B) . Probing with an anti-HA antibody confirmed this observation: increase in cytochrome c binding of both wt and S36A p66shc is due to their ectopic overexpression but not the endogenous p66shc. Importantly, H 2 O 2 Ser36 phosphorylates only the endogenous and exogenous wt but not mutant (S36A) p66shc. Reprobing with an anti-cytochrome c antibody showed equal pull down. Transient transfection of the cytochrome c binding-impaired mutant (W134F) decreased cytochrome c binding of p66shc in cells treated with H 2 O 2 (data not shown). Importantly, we found p66shc bound to the mitochondria (Fig. 5A ) in the postischemic (24 h) kidneys of mice: the average p66shc/cytochrome c ratio is 0.4 Ϯ 0.05 in control kidneys while it is 0.78 Ϯ 0.15 in the postischemic kidneys. Similarly, we determined cytochrome c binding of p66shc in the control vs. postischemic kidneys (Fig. 5B) : the p66shc/ cytochrome c ratio obtained by densitometry is 0.39 Ϯ 0.08 in the control but 2.12 Ϯ 0.35 in the postischemic kidneys. I/R injury-associated increase both in mitochondrial and cytochrome c binding is statistically significant (P Ͻ 0.05). It is important to note that there is no detectable cytochrome c release from the mitochondria in H 2 O 2 -treated cells (data not shown). Thus, we can exclude the possibility of the detection of a cytosolic p66shc/cytochrome c complex.
H 2 O 2 -induced mitochondrial depolarization requires Serine36 phosphorylation and cytochrome c binding of p66shc.
Effects of H 2 O 2 on mitochondrial polarity were determined by fluorescence microscopy after adding 200 M H 2 O 2 using the mitochondrial polarity-sensitive fluorescent dye JC-1 as described in METHODS. Untreated cells exhibit predominantly red fluorescence, which is consistent with a polarized mitochondrion. In contrast, green fluorescence (depolarized mitochondria) is predominant in H 2 O 2 -treated cells. Pretreatment with cyclosporine A (CsA), a known inhibitor of mitochondrial polarity transition, prevented H 2 O 2 -induced depolarization (Fig. 2, D-F) .
In the next step, we quantitated mitochondrial depolarization by measuring decrease in JC-1 aggregate (red) fluorescence in a fluorescent plate reader. Figure 6A shows that the red fluorescence significantly declines after H 2 O 2 treatment (vector), which is significantly attenuated in the p66shc k.d. cells or even further in the presence of CsA, a known inhibitor of MPT (29) . Also, while ectopic overexpression of the wild-type p66shc increases then the mutation in Serine36 phosphorylation (S36A) or cytochrome cbinding site (W134F) attenuates H 2 O 2 -induced mitochondrial depolarization (Fig. 6B) . These results indicate that p66shc, through binding to cytochrome c, is involved in the development of MPT. 
H 2 O 2 -induced mitochondrial ROS release mediates depolarization of the mitochondria.
In this set of experiments, we sought to answer whether mitochondrial ROS release is the cause or consequence of MPT? Accordingly, TKPTS cells were pretreated with the ETC inhibitors Rot or AntA before treatment with H 2 O 2 and mitochondrial depolarization was determined. Figure 7A shows that both inhibitors significantly attenuate mitochondrial depolarization. Since Rot inhibits ROS release (Fig. 1) , these data suggest that ROS generation is upstream from the MPT. This notion is further supported by the finding that neither CsA nor bongkrekic acid (BKA), inhibitors of MPT (29, 45) , inhibits H 2 O 2 -induced ROS generation (Fig. 7B) . 
H 2 O 2 -induced cytotoxicity is mitochondrial ROS-MPT mediated that requires
DISCUSSION
During renal I/R, a burst of ROS, including H 2 O 2 , release in the proximal tubules is seen that leads to opening of PTP and consequent necrotic cell death (32, 35, 37, 46) . One likely source of the excess ROS during I/R injury is the mitochondrial ETC (36, 49) , in particular the complex I (36) or complex III (12) . Inhibitors of complex I (Rot) or complex III (AntA) decrease mitochondrial ROS production in response to oxidative stress including ischemia (6, 12, 22, 23) . In our experiments, Rot and AntA but not the xanthine oxidase inhibitor Allo or the NAPDPH oxidase inhibitor DPI affected H 2 O 2 -induced ROS generation (Fig. 1A) , suggesting that the mitochondrial ETC is the source of the H 2 O 2 -induced ROS. This notion is further supported by fluorescence microscopy data: the generated ROS is colocalized with the mitochondria (Fig. 2A) .
Recently, it has been recognized that p66shc, a splice variant of the shcA family of adaptor proteins (43) , can augment ROS production (40) . The p66shc k.d. variant of TKPTS cell line (2) shows reduced levels of endogenous and H 2 O 2 -induced ROS generation (Fig. 3A) . Furthermore, overexpression of wild-type p66shc increased, while overepxression of Ser36 phosphorylation mutant (S36A) of p66shc attenuates ROS production after treatment with H 2 O 2 (Fig. 3B) . Hence, Ser36 phosphorylation is important for mitochondrial ROS production. Giorgio et al. (21) reported that p66shc generates mitochondrial H 2 O 2 utilizing the mitochondrial ETC through oxidation of cytochrome c. To exert this function, p66shc is imported into the mitochondrial intermembrane space, which requires Ser36 phosphorylation (41, 42) . Our results showed that a part of the cellular p66shc bound to the mitochondria under basal conditions, which was further elevated upon treatment with H 2 O 2 (Fig. 4A) . WT p66shc or the S36A mutant of p66shc is bound to the mitochondria after transient transfection but only binding of the wt p66shc increased after oxidative stress (Fig.  4A) . These results suggest that Ser36 phosphorylation is not necessary for basal binding but it is essential for the H 2 O 2 -stimulated mitochondrial localization. It is important to mention that a part of p66shc resides in the mitochondria without stress (Fig. 4A) as it was also shown by others (41, 42) . It is also important to note that Ser36-independent mitochondrial binding of p66shc has also been reported (47) .
Immunoprecipitation studies revealed that p66shc coprecipitates with cytochrome c after treatment with H 2 O 2 (Fig. 4B) . Also, overexpressed WT p66shc or its S36A mutant was coimmunoprecipitated with cytochrome c in unstimulated cells (Fig. 4B) . However, H 2 O 2 increased only binding of the WT p66shc to cytochrome c but not the S36A (Fig. 4B ) similar to mitochondrial binding (Fig. 4A) . Interestingly, the mitochondrial and cytochrome c-bound p66shc was Ser36 phosphorylated after treatment with H 2 O 2 (Fig. 4, A-B) . This is in odds with results by Pinton et al. (42) who suggested that Ser36 phosphorylation is important for mitochondrial transport of p66shc but it is dephosphorylated after being imported into the intermembrane space. This phenomenon requires further studies. Importantly, p66shc was associated with the mitochondria (Fig. 5A) and cytochrome c (Fig. 5B) in the kidneys of mice with I/R injury. These results, however, do not confirm the localization of p66shc in the proximal tubules. Previously, we showed that p66shc is coprecipitated with the activated EGFR in the postischemic kidneys of mice (2) . Since the EGFR is mostly expressed in the proximal tubules of the kidney (28) , these data indirectly suggest that p66shc is localized to the proximal tubules. Ectopic overexpression of the cytochrome c binding mutant (W134F) of p66shc decreased ROS production (Fig. 3B) and cytochrome c binding (data not shown) . These results confirm that cytochrome c binding of p66shc is important for ROS production as also evidenced by others (21, 47) . The in vivo results (Fig. 5) indicate that the p66shc/mitochondria/cytochrome c interaction might play a role in tubular injury in the postischemic kidney similar to the above described in vitro findings.
The MPT pore is a nonspecific pore that spans both the inner and outer mitochondrial membranes (25) . It is normally closed but various pathophysiological conditions can open it leading to decline in ATP synthesis and consequent necrosis as suggested for renal I/R injury (44) . The opening of this pore and consequent cell death can be prevented by either inhibitors of MPT such as CsA or BKA (7, 27) or by antioxidants (24, 27) . In this scenario, the pore opening is the consequence of an elevated ROS production (8) as opposed to the scenario when the pore opening is the cause of excessive ROS release (5) . Here, we show that H 2 O 2 -induced depolarization of the mitochondria (Fig. 6A) is significantly reduced in p66shc k.d. cells (Fig. 6A ) or by pretreatment with CsA (Figs. 6A and 2, D-F) but further exacerbated in cells that overexpress WT-p66shc (Fig. 6B) . We also found that mutation of the Ser36 phosphorylation (S36A) or cytochrome c-binding site (W134F) of p66shc attenuates depolarization (Fig. 6B) . These data suggest that both Ser36 phosphorylation and cytochrome c binding of p66shc are essential for mitochondrial depolarization. Considering that those residues are also important for ROS production (Fig. 3B) , we can state that ROS production is the cause and not a consequence of MPT. This notion is further supported by the findings that inhibition of the mitochondrial ETC inhibits depolarization (Fig. 7A) but inhibition of MPT does not affect H 2 O 2 -induced ROS production (Fig. 7B) .
Results in Fig. 8A show that H 2 O 2 -induced cytotoxicity is regulated via p66shc-dependent mitochondrial ROS production and consequent depolarization: k.d. or mutations of p66shc (S36A or W134F) and inhibitors of MPT (CsA or BKA) significantly decrease LDH release while overexpression of p66shc exacerbates it. The protective effects of CsA are somewhat surprising as it is considered as a nephrotoxic drug (10) . However, its toxicity depends on the concentration of the drug as well as duration of treatment (38) . At the applied concentration, CsA does not show cytotoxic effects in other proximal tubule cell line, either (50) . In addition, protective effects of CsA against oxidative damage have also been reported in vitro (15, 20, 24) and in vivo (13, 33, 39) .
In summary, our results suggest the following mechanism ( Fig. 8B) : oxidative stress increases S36A of p66shc that enhances its binding to the mitochondria and cytochrome c. The result is excessive generation of ROS (H 2 O 2 ) through the mitochondrial ETC, which, in turn, leads to opening of the PTP and consequent injury. Knockdown of p66shc or mutation of its Ser36 phosphorylation (S36A) or cytochrome c binding (W134F) site attenuates ROS production and consequent mitochondrial depolarization as well as injury. Thus, manipulating p66shc might offer a new therapeutic modality to ameliorate renal I/R injury. 
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